PCD logo

Announcements

Call for Papers: “Geospatial Perspectives on the Intersection of Chronic Disease and COVID-19”

Announcement posted 3/10/21

Deadline: Friday, December 3, 2021

Preventing Chronic Disease (PCD) welcomes submissions for this upcoming collection, which highlights the variety of ways in which geographic information systems (GIS), spatial analysis, and other geospatial techniques and technologies are applied to research and public health practice, addressing the intersection of chronic disease and COVID-19.

Background

The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), presents the greatest medical and public health challenge in decades. Medical professionals, public health experts, and the public are all scrambling to understand and respond to this crisis. People living with underlying chronic conditions are likely to bear the most severe effects of COVID-19, and some groups, such as those characterized by race and ethnicity, socioeconomic status, rural status, and other factors, have been historically and disproportionately affected by these underlying conditions. Furthermore, the negative effects of COVID-19 on people with chronic conditions are compounded by the lack of access to health care, economic instability, occupational characteristics, physical and built environments, and other social determinants of health in their lives and communities. Understanding the role of place and space in shaping the interactions of chronic disease and COVID-19 is critical to informing effective public health responses to the COVID-19 pandemic and promoting health equity. The application of spatial statistics, spatial epidemiology, location tracking, GIS, and other geospatial methods and technologies have provided opportunities to explore and address the geographic character of a wide range of COVID-19 and chronic disease-related outcomes, their relationships to risk factors, racial/ethnic disparities, access to health care, and nonpharmaceutical interventions intended to reduce COVID-19 transmission through social contact.

Research into the contributions of contextual, community-level factors moves beyond a narrow focus on individual-level risk factors and enables public health professionals to address underlying structural causes and advance health equity. Furthermore, advances in the delivery of place-based chronic disease data and maps via interactive websites and other geospatial tools provide public health professionals with opportunities to develop programs and policies, in partnership with others, tailored to the needs of specific communities. Understanding how to evaluate data from these sources is paramount as public health professionals navigate this burgeoning world of local-level chronic disease and COVID-19-related data.

This PCD collection will document research, translation, case studies, and analytic tools that have a geospatial perspective. PCD invites manuscripts that highlight the innovative and effective incorporation of place and space in addressing the intersection of chronic disease and COVID-19 to enhance surveillance, prevention, and treatment efforts, as well as public health interventions, public policy, health system changes, and beyond.

 

Topics of Interest

PCD encourages the submission of manuscripts within a diverse range of topics. Illustrative examples are included below. Please refer to the Types of Articles page on PCD’s website for the specifications of each article type. Examples that follow are not limited to other topics that are relevant to the collection:

  • Descriptive epidemiology of the spatial and/or spatio-temporal distributions of chronic disease and COVID-19 outcomes across the lifespan (children, adults, older adults)
  • The association of neighborhood or community attributes with chronic disease and COVID-19 outcomes
  • Use of geospatial technologies for digital contact tracing among populations with pre-existing conditions
  • Investigating geographic health disparities, social determinants of health, and community-level factors related to chronic disease and COVID-19 pandemic(s)
  • Long-term geospatial surveillance strategies of chronic disease among the people diagnosed with COVID-19
  • Use of GIS and geospatial analyses for COVID-19 vaccine delivery planning and implementation to ensure coverage of high-risk groups, including people with chronic disease, and equitable distribution
  • Maps that describe geographic variation in chronic disease and COVID-19 outcomes and/or risk factors, including social determinants of health, and community-level factors.
  • Maps that inform chronic disease and COVID-19-related policies, interventions, and/or programs
  • Maps used by local/state health departments in their response to chronic disease and COVID-19
  • Use of GIS by local and state health departments in response to chronic disease and COVID-19
  • Partnerships using GIS to effectively address service gaps (community, hospital or public health preparedness, social service needs)
  • Integrating the use of GIS with health communication principles to educate the public about chronic disease and COVID-19
  • Geospatial data ethical considerations related to chronic disease and COVID-19
  • Review of websites with small area, chronic disease-related data and mapping capabilities
  • Tools that support the use of small area chronic disease and COVID-19-related data

Submission Guidelines

While not required, corresponding authors are strongly encouraged to submit an inquiry to the journal in advance of submitting the manuscript to determine suitability. PCD asks that only the corresponding author submit inquiries to the journal for review. The corresponding author is the person who takes primary responsibility for communication with the journal during the submission, peer-review, and publication process if the paper is accepted.

The corresponding author’s inquiry should include the following information:

  • Article title
  • Name of the corresponding author
  • Author(s) name, degree, title, and affiliation
  • PCD article type (Visit: https://www.cdc.gov/pcd/for_authors/types_of_articles.htm)
  • Has the article ever been submitted elsewhere for consideration? If yes, please indicate the name of the journal, the date of the final decision, and an explanation of the decision.
  • Indicate that this inquiry is related to the Call for Papers.
  • Abstract (300 words or less) with the following information:
    • Study/intervention/project description
    • Dates when program/policy/study was conducted
    • Dates when data were collected
    • Research methods and data analyses
    • Findings
    • Implications for public health practice

 

PCD will provide feedback to the corresponding author about the journal’s interest in the proposed manuscript and guidance on what information is needed. Corresponding authors should submit their inquiry to the Editor in Chief at PCDeditor@cdc.gov for consideration on or before June 4, 2021. Complete manuscripts should be submitted to PCD on or before Friday, December 3, 2021. If accepted, your manuscript will be reviewed and published on a rolling basis. Articles will be assembled into a PDF collection accessible on the PCD website after all accepted papers have been published. Cover letters to the Editor in Chief are required and must state that the submission is for consideration in the PCD collection: Geospatial Perspectives on the Intersection of Chronic Disease and COVID-19.

About the Journal

PCD is a peer-reviewed public health journal sponsored by the Centers for Disease Control and Prevention and authored by experts worldwide. PCD was established in 2004 by the National Center for Chronic Disease Prevention and Health Promotion with a mission to promote dialogue among researchers, practitioners, and policy makers worldwide on the integration and application of research findings and practical experience to improve population health. For more information about the journal, please visit https://www.cdc.gov/pcd.

 

 

Call for Papers: “COVID-19 & Chronic Diseases: Burden, Access to Care, Community Engagement, and Partnerships”

Announcement posted 2/18/21

Chronic diseases have exacted a heavy burden on the adult population and account for leading causes of death globally. Many chronic diseases (eg, cancer, cardiovascular diseases, diabetes, chronic kidney disease) and risk factors (such as obesity and smoking) increase the severity of COVID-19 outcomes. Consequently, rates of hospitalization and fatality due to COVID-19 increase as the number of conditions increase. COVID-19 can further exacerbate the health conditions of individuals living with a chronic disease given that COVID-19 is a complex multisystem disorder that can affect multiple organs and tissues. Further, patients with chronic conditions report not engaging in recommended preventive health care due to the fear of COVID-19 infection.

The COVID-19 pandemic affects not only health, but also health care, social, and economic systems worldwide. The COVID-19 pandemic has also heightened anxiety and psychological stress among medical professionals, patients who have contracted the virus, family members, and the public who have been encouraged to change their day-to-day routines due to fear of infection. Emerging data also indicate that racial and ethnic groups are at an increased risk of serious illness and death from COVID-19. Persistent social determinants further compound the negative effects that COVID-19 has on people with a chronic condition. Examples of social determinants of health that have brought to light these disparities in health outcomes include unstable housing, racism, limited access to nutritious food, inadequate transportation, and low socioeconomic status.

Given the length of the pandemic, strengthening the evidence on the associations between chronic diseases, risk factors for chronic diseases, social determinants of health, and COVID-19 is therefore an urgent priority in public health.  In August of 2020, The CDC journal, Preventing Chronic Disease (PCD), released a supplement, “US Public Health Response to COVID-19 and Chronic Disease: Continuing the Commitment to Improve Population Health.” This supplement features commentaries addressing areas in which future submissions would be of great interest to the journal. Topics include men and COVID-19, behavioral health during the COVID-19 pandemic, importance of culture in communicating a global response to COVID-19, geographic information science in response to COVID-19, parks and green space during COVID-19, creating healthy schools during COVID-19, oral health and COVID-19, pharmacist-led chronic care management, and engaging racial and ethnic minority communities in rural and urban settings.

PCD seeks to expand these topics, along with these additional examples:

  • COVID-19 incidence and fatality among adults with chronic conditions by urban–rural classification
  • Racial and ethnic disparities in COVID-19 vaccination rates and access among adults with chronic disease
  • Health-related behavioral risk factors related to chronic conditions
  • Racial and ethnic disparities in COVID-19 incidence and receiving medical treatment among adults with chronic conditions
  • The influence/impact of social determinants of health on chronic disease and COVID-19 pandemic among vulnerable populations
  • Structural racism, chronic disease management, and COVID-19
  • Designing and evaluating multilevel interventions to reduce health disparities related to COVID-19 and chronic disease
  • Health communication related to COVID-19 and chronic diseases in rural and urban communities
  • Cultural considerations when creating risk communication messages about COVID-19 and chronic diseases
  • Use of preventive services during the COVD-19 pandemic
  • The impact of housing and residential segregation on chronic disease and COVID-19
  • Impact of COVID-19 on food access and availability
  • Impact of COVID-19 on mental and psychological health among adults with chronic conditions
  • Social isolation or lockdown and its impact on chronic diseases and behavioral risk factors (eg, physical activity, obesity, nutrition)
  • COVID vaccine and access for adults with chronic conditions
  • Pharmacists/pharmacies addressing disease management and enhancing access to COVID-19 vaccination to the general population and those at highest risk
  • Public–private partnership collaborations generating population-health responses to COVID-19 and chronic disease

While not required, corresponding authors are strongly encouraged to submit an inquiry to the journal in advance of submitting the manuscript to determine the suitability of the manuscript for PCD. PCD asks that only the corresponding author submit inquiries to the journal for review. The corresponding author is the individual who takes primary responsibility for communication with the journal during the manuscript submission, peer-review, and publication process (should the paper be accepted).

The corresponding author’s inquiry should include the following information:

  • Article title
  • Name of the corresponding author
  • Author(s) name, degree, title, and affiliation
  • PCD article type (Visit: https://www.cdc.gov/pcd/for_authors/types_of_articles.htm)
  • Has the article ever been submitted elsewhere for consideration? If yes, please indicate the name of the journal, the date of the final decision, and an explanation of the decision.
  • Indicate that this inquiry is related to the Call for Papers.
  • Abstract (300 words or less) with the following information:
    • Study/intervention/project description
    • Dates when program/policy/study was conducted
    • Dates when data were collected
    • Research methods and data analyses
    • Findings
    • Implications for public health practice

 

PCD will provide feedback to the corresponding author about the journal’s interest in the proposed paper and guidance on what information is needed. Corresponding authors should submit their inquiry to the Editor in Chief at PCDeditor@cdc.gov for consideration on or before Friday, April 2, 2021. Articles (manuscripts) should be submitted to PCD on or before Friday, October 1, 2021. All articles submitted in response to this call for papers will be reviewed and, if accepted, published on a rolling basis. All published articles will be presented as a PDF collection accessible on the journal’s website. PCD offers a range of article types, all of which have specific formatting instructions. Cover letters to the Editor in Chief are required and must state that the submission is for consideration in the PCD collection: “COVID-19 & Chronic Diseases: Burden, Access to Care, Community Engagement, and Partnerships.” 

About the Journal
PCD is a peer-reviewed public health journal sponsored by the Centers for Disease Control and Prevention and authored by experts worldwide. PCD was established in 2004 by the National Center for Chronic Disease Prevention and Health Promotion with a mission to promote dialogue among researchers, practitioners, and policy makers worldwide on the integration and application of research findings and practical experience to improve population health. For more information about the journal, please visit https://www.cdc.gov/pcd.

 

 

Top 10 Most Talked About Articles of 2020

Announcement posted 1/4/21

Preventing Chronic Disease (PCD) is excited to announce its most popular articles of 2020, as rated by Altmetric. Thousands of conversations about scholarly content happen online every day. Altmetric tracks a range of sources to capture, collate, and score this activity.

 

  1. Men and COVID-19: A Biopsychosocial Approach to Understanding Sex Differences in Mortality and Recommendations for Practice and Policy Interventions
  2. Trends in Adolescent Treatment Admissions for Marijuana in the United States, 2008–2017
  3. Emergency Preparedness and Risk Communication Among African American Churches: Leveraging a Community-Based Participatory Research Partnership COVID-19 Initiative
  4. Reaching the Hispanic Community About COVID-19 Through Existing Chronic Disease Prevention Programs
  5. Recommendations for Keeping Parks and Green Space Accessible for Mental and Physical Health During COVID-19 and Other Pandemics
  6. The Influence of Metabolic Syndrome in Predicting Mortality Risk Among US Adults: Importance of Metabolic Syndrome Even in Adults With Normal Weight
  7. Oral Health and COVID-19: Increasing the Need for Prevention and Access
  8. The Critical Need for a Population Health Approach: Addressing the Nation’s Behavioral Health During the COVID-19 Pandemic and Beyond
  9. An Overview of Social Media Use in the Field of Public Health Nutrition: Benefits, Scope, Limitations, and a Latin American Experience
  10. Community Pharmacists’ Contributions to Disease Management During the COVID-19 Pandemic

 

 


The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.

Page last reviewed: March 10, 2021, 12:00 AM